Pylote is participating at CPhI Japan in Tokyo on April 2017 to promote its innovations providing antimicrobial protection in the pharmaceutical and cosmetics industries.
During this most comprehensive pharma event, which brings together more than 20,000 pharma industry professionals from 100+ countries, Loïc Marchin, CEO of Pylote, will hold a conference on April 20 at 11:00 am on the beneficial effects of its breakthrough proprietary innovation PYCLEARTM PROTECTION providing antimicrobial protection in many pharmaceutical and cosmetics specialties.
This presence of Pylote at CPhI Japan is part of its 2017 commercial development in Japan with the active and concrete support of Business France, the French national agency supporting the international development of the French economy and responsible for fostering export growth by French businesses.
Loïc Marchin, CEO of Pylote, said: “Pylote is today able to provide in the Japan pharmaceutical & cosmetic markets its proprietary solutions with complete statutory compliance such as Japanese, European and US pharmacopeias or Food Contact. Our solutions are totally ready to use and adaptable to every type of packaging, manufacturer & contents."
In the recent months, Pylote has conducted in Europe a whole set of agreements with key major players in packaging solutions, such as Argo in October 2016, for mutual referencing to provide innovative packaging solutions for greener, cleaner and safer unpreserved pharmaceutical specialties & ophthalmic products. Pylote intends to set such type of partnerships with major key players on these industries in Japan.
Today, Pylote, with its exclusive manufacturing process, has more than 200 partnerships with industry worldwide and more than 50 to provide CE marking & AMM products.